BioPorto Diagnostics A/S

Grusbakken 8
2820 Gentofte

Phone: +45 45290000
Fax: +45 45290001


Company Figures
Number of employees 20-49
Sales volume 1-9 Mio US $
Export content > 75%
Year of foundation 2001
Area of business Diagnostics

Company Profile

BioPorto Diagnostics A/S

BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector. The Company’s developments include a test (NGAL) to diagnose and monitor acute kidney damage.

BioPorto’s strategy is to develop new methods based on its antibody portfolio that can be patented and achieve a wide use in the diagnosis of various diseases.

BioPorto was founded in 2000 and has about 25 employees. The Company’s shares are listed on OMX Nordic Exchange Copenhagen (symbol: BIOPOR).

Biopol Co., Ltd.
Bionime GmbH
Bionics Corporation
Bionet Co., Ltd.
Biometrix Technology Inc.

Biopsybell S.r.l.
Bioptik Technology, Inc.
BioRepair GmbH
BIOS Naturprodukte GmbH
Bios S.r.l.